Patients Retaining the human quality of healthcare in DTx As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic,
R&D Worrying signs for trial diversity require broad industry ac... A recent report found that diversity in clinical trials has dropped.
Digital Generative Health: A new standard of care The pervasive impact of generative AI will leave no industry untouched, and healthcare is no outlier.
Patients Eliminating disruption with Eddy Effect metric elevates CX Between ongoing drug shortages, navigating complex insurance benefits, understanding the confusing language of
Patients How healthcare can offer patients a digital bedside manner Healthcare is in flux. Even before the pandemic, private and public sector organisations wrestled with multiple challenges
Patients Driving improved and equitable outcomes for IBD patients acr... Long-term immunological conditions, including inflammatory bowel disease (IBD), have a significant impact on patients’ lives.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.